Clinical Trial Update: CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluating CytoSorbents' CytoSorb device for reducing free hemoglobin during elective cardiac surgery; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery Related Conditions
• Heart Disease

Drugs mentioned

• CytoSorb

Snippet

Sponsor: CytoSorbents, Inc | Conditions: Elective Cardiac Surgery | NA | Status: COMPLETED | Results posted: 2021-08-20